|
1
|
Scott MA, Levi B, Askarinam A, Nguyen A,
Rackohn T, Ting K, Soo C and James AW: Brief review of models of
ectopic bone formation. Stem Cells Dev. 21:655–667. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Łęgosz P, Drela K, Pulik Ł, Sarzyńska S
and Małdyk P: Challenges of heterotopic ossification-molecular
background and current treatment strategies. Clin Exp Pharmacol
Physiol. 45:1229–1235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi L, Sun W, Gao F, Cheng L and Li Z:
Heterotopic ossification related to the use of recombinant human
BMP-2 in osteonecrosis of femoral head. Medicine (Baltimore).
96:e74132017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pulido R: PTEN inhibition in human disease
therapy. Molecules. 23:2852018. View Article : Google Scholar
|
|
5
|
Papa A and Pandolfi PP: The PTEN-PI3K axis
in cancer. Biomolecules. 9:1532019. View Article : Google Scholar
|
|
6
|
Liu X, Bruxvoort KJ, Zylstra CR, Liu J,
Cichowski R, Faugere MC, Bouxsein ML, Wan C, Williams BO and
Clemens TL: Lifelong accumulation of bone in mice lacking Pten in
osteoblasts. Proc Natl Acad Sci USA. 104:2259–2264. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burgers TA, Hoffmann MF, Collins CJ,
Zahatnansky J, Alvarado MA, Morris MR, Sietsema DL, Mason JJ, Jones
CB, Ploeg HL, et al: Mice lacking pten in osteoblasts have improved
intramembranous and late endochondral fracture healing. PLoS One.
8:e638572013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiong Y, Cao F, Hu L, Yan C, Chen L,
Panayi AC, Sun Y, Zhou W, Zhang P, Wu Q, et al: miRNA-26a-5p
accelerates healing via downregulation of PTEN in fracture patients
with traumatic brain injury. Mol Ther Nucleic Acids. 17:223–234.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kawamura N, Kugimiya F, Oshima Y, Ohba S,
Ikeda T, Saito T, Shinoda Y, Kawasaki Y, Ogata N, Hoshi K, et al:
Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS
One. 2:e10582007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ghosh-Choudhury N, Abboud SL, Nishimura R,
Celeste A, Mahimainathan L and Choudhury GG: Requirement of
BMP-2-induced phosphatidylinositol 3-kinase and Akt
serine/threonine kinase in osteoblast differentiation and
Smad-dependent BMP-2 gene transcription. J Biol Chem.
277:33361–33368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beck SE and Carethers JM: BMP suppresses
PTEN expression via RAS/ERK signaling. Cancer Biol Ther.
6:1313–1317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mukherjee A and Rotwein P: Akt promotes
BMP2-mediated osteoblast differentiation and bone development. J
Cell Sci. 122:716–726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mukherjee A, Wilson EM and Rotwein P:
Selective signaling by Akt2 promotes bone morphogenetic protein
2-mediated osteoblast differentiation. Mol Cell Biol. 30:1018–1027.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao L, Li G, Chan KM, Wang Y and Tang PF:
Comparison of multipotent differentiation potentials of murine
primary bone marrow stromal cells and mesenchymal stem cell line
C3H10T1/2. Calcif Tissue Int. 84:56–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee CH, Jin MU, Jung HM, Lee JT and Kwon
TG: Effect of dual treatment with SDF-1 and BMP-2 on ectopic and
orthotopic bone formation. PLoS One. 10:e01200512015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Egan KP, Brennan TA and Pignolo RJ: Bone
histomorphometry using free and commonly available software.
Histopathology. 61:1168–1173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsubara T, Kida K, Yamaguchi A, Hata K,
Ichida F, Meguro H, Aburatani H, Nishimura R and Yoneda T: BMP2
regulates Osterix through Msx2 and Runx2 during osteoblast
differentiation. J Biol Chem. 283:29119–29125. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR,
Kyung HM, Sung JH, Wozney JM, Kim HJ and Ryoo HM: BMP-2-induced
Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the
BMP-2-induced osteoblast differentiation by suppression of Dlx5
expression. J Biol Chem. 278:34387–34394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bain G, Müller T, Wang X and Papkoff J:
Activated beta-catenin induces osteoblast differentiation of
C3H10T1/2 cells and participates in BMP2 mediated signal
transduction. Biochem Biophys Res Commun. 301:84–91. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ogasawara T, Kawaguchi H, Jinno S, Hoshi
K, Itaka K, Takato T, Nakamura K and Okayama H: Bone morphogenetic
protein 2-induced osteoblast differentiation requires Smad-mediated
down-regulation of Cdk6. Mol Cell Biol. 24:6560–6568. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hashimoto K, Kaito T, Furuya M, Seno S,
Okuzaki D, Kikuta J, Tsukazaki H, Matsuda H, Yoshikawa H and Ishii
M: In vivo dynamic analysis of BMP-2-induced ectopic bone
formation. Sci Rep. 10:47512020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y, Whetstone HC, Youn A, Nadesan P,
Chow EC, Lin AC and Alman BA: Beta-catenin signaling pathway is
crucial for bone morphogenetic protein 2 to induce new bone
formation. J Biol Chem. 282:526–533. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoshi K, Amizuka N, Sakou T, Kurokawa T
and Ozawa H: Fibroblasts of spinal ligaments pathologically
differentiate into chondrocytes induced by recombinant human bone
morphogenetic protein-2: Morphological examinations for
ossification of spinal ligaments. Bone. 21:155–162. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamada KM and Araki M: Tumor suppressor
PTEN: Modulator of cell signaling, growth, migration and apoptosis.
J Cell Sci. 114:2375–2382. 2001.PubMed/NCBI
|
|
26
|
Waite KA and Eng C: BMP2 exposure results
in decreased PTEN protein degradation and increased PTEN levels.
Hum Mol Genet. 12:679–684. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iwasa K, Hayashi S, Fujishiro T, Kanzaki
N, Hashimoto S, Sakata S, Chinzei N, Nishiyama T, Kuroda R and
Kurosaka M: PTEN regulates matrix synthesis in adult human
chondrocytes under oxidative stress. J Orthop Res. 32:231–237.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ford-Hutchinson AF, Ali Z, Lines SE,
Hallgrimsson B, Boyd SK and Jirik FR: Inactivation of Pten in
osteo-chondroprogenitor cells leads to epiphyseal growth plate
abnormalities and skeletal overgrowth. J Bone Miner Res.
22:1245–1259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yan L, Gao R, Liu Y, He B, Lv S and Hao D:
The pathogenesis of ossification of the posterior longitudinal
ligament. Aging Dis. 8:570–582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biz C, Pavan D, Frizziero A, Baban A and
Iacobellis C: Heterotopic ossification following hip arthroplasty:
A comparative radiographic study about its development with the use
of three different kinds of implants. J Orthop Surg Res.
10:1762015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang J, Nie J, Ma X, Wei Y, Peng Y and Wei
X: Targeting PI3K in cancer: Mechanisms and advances in clinical
trials. Mol Cancer. 18:262019. View Article : Google Scholar : PubMed/NCBI
|
